Ruxolitinib for the Treatment of Inadequately Controlled Polycythemia Vera without Splenomegaly: 156-Week Follow-up from the Phase 3 Response-2 Study
Bildiriler > Tam Metin Bildiri · 2018
Yazarlar: Francesco PASSAMONTİ, Francesco PALLANDİRİ, Güray SAYDAM, Giulia BENOVOLO, Miklos EGYED, Jeannie CALLUM, Timothy DEVOS, Serdar ŞIVGIN, Paola GUGLİELMELLİ, Alessandro VANUCCHİ, Caroline BENSASSON, Albert KANDRA, Juliane MORANDO, Martin GRİESSHAMMER
ASH 2018, Uluslararası, Poster, Tam Metin Bildiri, 2018-2018